Alfonso Quintas Cardama - Dec 15, 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC. (TCRR)

Role: Chief Medical Officer
Signature: /s/ Margaret Siegel as Attorney-in-Fact
Stock symbol: TCRR
Transactions as of: Dec 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/19/2022, 04:44 PM
Previous filing: Dec 13, 2022
Next filing: Jun 1, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TCRR	Common Stock						109K	Dec 15, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TCRR	Stock Option (Right to Buy)	Award	$0	+70.6K		$0.00	70.6K	Dec 15, 2022	Common Stock	70.6K	$0.97	Direct	F1
transaction	TCRR	Restricted Stock Unit (Right to Buy)	Award	$0	+11.8K		$0.00	11.8K	Dec 15, 2022	Common Stock	11.8K		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of this option shall vest and become exercisable on the one-year anniversary of the date of grant, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
F2	Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
F3	The restricted stock units will vest 25% on the one-year anniversary of the date of grant, with the remainder vesting in three equal annual installments thereafter.